Method for colorectal cancer prognosis and treatment selection
US6322986A · kind A · utility
25Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 18, 2000 |
| Grant date | Nov 27, 2001 |
| Priority date | — |
| Expiry date | Jan 18, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/118
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method predicting the outcome, and prognosis and indicating treatment for patients afflicted with colorectal cancer by determining whether the number of copies of HER-2/neu gene in cancer cells from the patient exceeds four by in-situ hybridization. Patients having cells with five or more copies of the HER-2/neu gene are to be treated more aggressively or in combination with an anti-HER-2/neu antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.